PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 10/31/2017) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
85873460 |
LAW OFFICE ASSIGNED |
LAW OFFICE 117 |
MARK SECTION |
MARK |
ZEAV |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ZEAV |
OWNER SECTION |
NAME |
Eli Lilly and Company |
STREET |
Lilly Corporate Center |
CITY |
Indianapolis |
STATE |
Indiana |
ZIP/POSTAL CODE |
46285 |
COUNTRY |
United States |
PHONE |
317-276-9624 |
FAX |
317-276-1919 |
EMAIL |
XXXX |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases
in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals;
medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely,
ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary
preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on
livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents to identify pathogens and residues of biological
interest for veterinary use; Veterinary preparations for companion animals for the treatment of parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral
diseases, pain, inflammation and gastrointestinal disorders; Veterinary preparations for companion animals for the treatment of central nervous system disorders, neurological and neurodegenerative
disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions; Veterinary preparations for companion animals for the treatment of osteoarthritis, otitis, wound
healing, infections, allergy atopic conditions, liver diseases and disorders; Veterinary preparations for companion animals for the treatment of nonsurgical sterilization, namely, hormones for the
prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
10/08/2013 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/reljr44/ |
SIGNATORY'S NAME |
Robert E. Lee, Jr. |
SIGNATORY'S POSITION |
Assistant General Patent Counsel |
DATE SIGNED |
09/25/2014 |
SIGNATORY'S PHONE NUMBER |
317-276-9624 |
FILING INFORMATION |
SUBMIT DATE |
Thu Sep 25 14:33:29 EDT 2014 |
TEAS STAMP |
USPTO/ESU-XX.X.XX.XX-2014
0925143329527848-85873460
-5002ee837c985ef898eb79bd
f7f3d44534d9e2be0a26281d1
7969afe917e98014-DA-743-2
0140925071633211984 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 10/31/2017) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ZEAV
SERIAL NUMBER: 85873460
The applicant, Eli Lilly and Company, having an address of
Lilly Corporate Center
Indianapolis, Indiana 46285
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 10/08/2013.
For International Class 005:
Current identification: Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and
livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water
additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and
parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal
processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit
microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents to identify pathogens and residues of biological interest for veterinary use; Veterinary
preparations for companion animals for the treatment of parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation and
gastrointestinal disorders; Veterinary preparations for companion animals for the treatment of central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular
conditions, dermatologic conditions, urogenital and urinary conditions; Veterinary preparations for companion animals for the treatment of osteoarthritis, otitis, wound healing, infections, allergy
atopic conditions, liver diseases and disorders; Veterinary preparations for companion animals for the treatment of nonsurgical sterilization, namely, hormones for the prevention of reproductive
functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and
that all statements made on information and belief are believed to be true.
Signature: /reljr44/ Date Signed: 09/25/2014
Signatory's Name: Robert E. Lee, Jr.
Signatory's Position: Assistant General Patent Counsel
Signatory's Phone: 317-276-9624
RAM Sale Number: 85873460
RAM Accounting Date: 09/26/2014
Serial Number: 85873460
Internet Transmission Date: Thu Sep 25 14:33:29 EDT 2014
TEAS Stamp: USPTO/ESU-XX.X.XX.XX-2014092514332952784
8-85873460-5002ee837c985ef898eb79bdf7f3d
44534d9e2be0a26281d17969afe917e98014-DA-
743-20140925071633211984